Posts Tagged ‘Clinical Therapeutics’

Vesicoureteral Reflux

Posted by Sara Fazio • March 30th, 2012

In the latest article in our Clinical Therapeutics series, a 7-year-old girl with persistent, moderately severe vesicoureteral reflux has recurrent urinary tract infections while receiving prophylactic antibiotic therapy. Endoscopic correction of vesicoureteral reflux is recommended. The technique is described. Primary vesicoureteral reflux is the most common urologic abnormality in children. The overall prevalence of the disorder… Read More…

Catheter Ablation for Atrial Fibrillation

Posted by Sara Fazio • December 16th, 2011

The latest article in our Clinical Therapeutics series begins with a 59-year-old man who presents with a recurrent episode of symptomatic atrial fibrillation despite attempts to maintain sinus rhythm with antiarrhythmic drugs. Catheter ablation can be effective in such patients, but more than one procedure may be necessary. Atrial fibrillation affects up to 5 million… Read More…

Erlotinib or Gefitinib for Lung Cancer

Posted by Graham McMahon • March 11th, 2011

The latest article in our Clinical Therapeutics series, Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib, comes from Dr. Vince Cataldo at the Louisiana State University Health Sciences Center and Hematology–Oncology Clinic, Drs. Don Gibbons and Alfonso Quintás-Cardama at Montefiore Medical Center, and Dr. Román Pérez-Soler at Albert Einstein College of Medicine. Advanced-stage non-small-cell… Read More…

Macular Degeneration

Posted by Graham McMahon • October 22nd, 2010

In the latest article in our Clinical Therapeutics series, “Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration,” Drs. James Folk and Edwin Stone present the case vignette of a 66-year-old man with a 2-week history of blurred and distorted vision in his right eye. A retinal specialist diagnoses neovascular age-related macular degeneration (AMD) and recommends treatment… Read More…

Therapeutic Hypothermia

Posted by Graham McMahon • September 24th, 2010

The latest article in our Clinical Therapeutics series, “Targeted Temperature Management for Comatose Survivors of Cardiac Arrest,” comes from Dr. Michael Holzer at the Medical University of Vienna. Targeted temperature management, also known as therapeutic hypothermia, is a therapeutic intervention that is intended to limit neurologic injury after a patient’s resuscitation from cardiac arrest. Hypothermia… Read More…